Recruiting
Phase 1
Phase 2

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Sponsor:

National Cancer Institute (NCI)

Code:

NCT04941274

Conditions

Kaposi Sarcoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abemaciclib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information